Promoting and facilitating strategies to improve cardiovascular health worldwide
-
Conferences & Events
Organising high level conferences featuring presentations, seminars and discussions and attended by world-renowned consultants.
-
Webinars & e‑Learning
Specific training and best-practice modules, including ISCP on-demand webinars and ISCP-endorsed webinars
-
Expert Reviews & Analysis
Expert Reviews, Opinions and Brief Reports. Independent summary information to keep you up to date with the latest research.
-
Drug Interaction Database
A reference tool for cardiovascular physicians and surgeons, pharmacists, pharmacologists, scientists and medical practitioners.
Call For Abstracts Now Open!
for ISCP 2025 Annual Scientific Meeting
Dear ISCP Colleagues & Friends,
The 30th Congress of the International Society of Cardiology 2025 ISCP will be held on September 25 and 26 at the Ciudad de Oviedo Exhibition and Congress Center and is aimed at all professionals working in the field of cardiovascular pharmacotherapy. This congress will be held in conjunction with the Spanish Society of Cardiology.
The deadline for submitting your abstract is June 30 2025. The conference's scientific committee will evaluate papers submitted through the conference website from July 1 to 22. The abstract should be presented in poster format, and the scientific committee will select the three best for oral presentation. The results of the evaluation will be officially communicated to the authors starting on July 23rd . Authors with accepted papers must complete their registration for the conference before September 1. Full Guidelines and further information can be accessed on the meeting website.
A-Z of CV Pharmacotherapy:
ISCP Webinar Series
The latest additions to our A to Z of CV Pharmacotherapy programme are available to view in the Webinars On Demand section:
6- Managing Iron Deficiency in Heart Failure: Practical Considerations
5-Anticoagulation Stewardship – Let´s start a Global Revolution
4- Treating Cardiometabolic Syndromes – What’s The Best Approach?
3- Decongesting the current diuretic landscape in Heart Failure
2- Digitalising Care for Hypertension: One for All, All for One
1- Statin’ the source of that pain: Pharmacogenomics As A Preemptive Tool
Details of future webinars are available in Upcoming webinars , including the next series of our own A to Z of CV Pharmacotherapy programme
Have you watched one or more of the above sessions? We value your opinion. Take 3 minutes to give us feedback on the series.
Upcoming Events
14
May
29
Aug
ESC 2025 MADRID
Conferences 29 Aug 2025
25
Sep
ISCP 2025 SPAIN
Annual Meeting, Conferences 25 Sep 2025
Highlights
The latest reviews, resources and expert analysis from our website.
newsfeed
Trial Scorecard: Advance-HTN
Posted on May 13, 2025
The Advance-HTN trial compared treatment with the aldosterone synthase inhibitor lorundrostat vs. placebo for blood pressure reduction among adults with treatment-resistant hypertension.Read... more
Tirzepatide bests semaglutide for weight loss in adults with obesity
Posted on May 13, 2025
Tirzepatide conferred significantly greater weight loss than semaglutide at 72 weeks for adults with overweight or obesity, according to findings from the... more
Obicetrapib improves lipid profiles for patients with genetic high cholesterol or ASCVD
Posted on May 13, 2025
Obicetrapib monotherapy significantly improved the lipid profile of patients with heterozygous familial hypercholesterolemia or atherosclerotic CVD and uncontrolled LDL vs. placebo, a... more
Trump signs executive order meant to bring down drug prices
Posted on May 12, 2025
President Donald J. Trump on Monday signed an executive order aimed at requiring “most favored nation” prices for some medications, which he... more
ISCP book series
Current Cardiovascular Therapy
Kaski, Juan Carlos.
Series Editor: Juan Carlos Kaski Cardiovascular pharmacotherapy is a fast-moving and complex discipline within cardiology in general. New studies, trials and indications are appearing on a regular basis. This series created with the support of the International Society of Cardiovascular Pharmacotherapy (ISCP) is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis. The information within is designed to allow readers to learn quickly and with certainty the mode of action,...
-
Antiplatelet and Anticoagulation Therapy
A. Ferro, D.A. Garcia (Eds.)
-
Pharmacological Treatment of Acute Coronary Syndromes
Avanzas, Pablo; Clemmensen, Peter(Eds.)
-
Atrial Fibrillation Therapy
Gheorghe-Andrei Dan, Antoni Bayes de Luna, John Camm(Eds.)
board of directors
Providing a leadership and advocacy role amongst members of their national societies.
-
Alberto Lorenzatti
President
Dr. Alberto J. Lorenzatti is currently the Co-Director of the DAMIC Medical Institute / Rusculleda Foundation for Research, Teaching and Patient Care (Head of the Clinical Research network with more than 30 research sites in Argentina) and he was the Chief of Cardiology at the Cordoba Hospital, Cordoba, Argentina... more
-
Thomas Kahan
Past President
Affiliations/Memberships Professor of Medicine Department of Clinical Sciences, Danderyd Hospital Division of Cardiovascular Medicine (more…) more
-
Sang Hong Baek
Board Member
Sang Hong Baek is a Board Member of ISCP and also Governor for the Republic of Korea. ISCP Governors act as representatives for different countries worldwide to encourage local participation and contribute to the ISCP's educational programmes. Past president of the ISCP Professor Sang Hong Baek is Director of Heart... more
-
Pablo Avanzas
Secretary
Professor Pablo Avanzas is Director of Invasive Cardiology at Hospital Universitario Central de Asturias and Full Professor of Cardiology at University of Oviedo in Asturias, Spain. Affiliations/Memberships • Full Professor of Cardiology, University of Oviedo, Oviedo, Spain. • Director of Invasive Cardiology at Hospital Universitario Central de Asturias, Oviedo,... more
